Connor, Clark & Lunn Investment Management (CC&L)’s Cardiovascular Systems, Inc. CSII Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-87,600	Closed	-$1.19M	–	1513
2022 Q4	$1.19M	Buy	87,600 +13,995	+19%	+$195K	0.01%	667
2022 Q3	$1.02M	Buy	73,605 +43,437	+144%	+$645K	0.01%	651
2022 Q2	$433K	Buy	30,168 +21,014	+230%	+$365K	﹤0.01%	813
2022 Q1	$207K	Buy	+9,154	New	+$178K	﹤0.01%	939
2018 Q4	–	Sell	-23,225	Closed	-$909K	–	1070
2018 Q3	$909K	Buy	+23,225	New	+$859K	0.01%	583
2017 Q3	–	Sell	-33,287	Closed	-$1.07M	–	946
2017 Q2	$1.07M	Sell	33,287 -11,663	-26%	-$355K	0.01%	487
2017 Q1	$1.27M	Buy	44,950 +19,400	+76%	+$515K	0.01%	460
2016 Q4	$619K	Sell	25,550 -14,450	-36%	-$355K	﹤0.01%	564
2016 Q3	$950K	Buy	40,000 +29,800	+292%	+$652K	0.01%	476
2016 Q2	$187K	Buy	+10,200	New	+$159K	﹤0.01%	750

Other funds holding CSII

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s CSII Position: Q1 2023 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2023, closing a stake of 87,600 shares — an estimated $1.19M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CSII in Q2 2016 and held it in 10 quarters. The position peaked at $1.27M in Q1 2017. 150 funds tracked by Wall St. Rank hold CSII as of Q1 2023.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Cardiovascular Systems, Inc. position as of Q1 2023 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 87,600 Cardiovascular Systems, Inc. shares in Q1 2023, an estimated $1.19M.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Cardiovascular Systems, Inc. in Q2 2016 and held it in 10 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Cardiovascular Systems, Inc. position peaked at $1.27M in Q1 2017.
150 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2023.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2023, filed 10 May 2023.